Assessing the impact and cost-effectiveness of needle and syringe provision and opioid substitution therapy on hepatitis C transmission among people who inject drugs in the UK: an analysis of pooled data sets and economic modelling.

Opiate substitution therapy together with needle/syringe programmes (NSPs) probably reduce the risk of hepatitis C acquisition; and NSPs are likely to be good value for money and even cost saving in some settings.

http://ift.tt/2yVxINJ